Medisys PLC (MDY) Providing innovative solutions to the rapidly growing point-of-care diagnostic and healthcare worker safety markets. For more than 35 years, companies in the Medisys group have been advancing healthcare through development, manufacture and distribution of revolutionary medical products. The Group's mission is to become a leading worldwide provider of diagnostic systems and medical safety products enabling rapid, cost effective, on-site delivery of healthcare solutions.
For more than three decades, Medisys' primary operating unit, Hypoguard, has been devoted to advancing personal and professional healthcare management. The Company's core focus is diabetes glucose self-monitoring - a rapidly growing market of nearly $5 billion worldwide.
'Medisys-group.com'
'Hypoguard.com'

15/02/2006
Medisys reported a 'considerable improvement' in trading during the first four months of its financial year, and said the business has been cash-flow neutral for the year to date.
The medical products company said competition in its core long-term care blood glucose monitoring business has not intensified. A drop in sales amid intense competition in the market caused a fall in sales and profits last year.
Sales volumes have recovered to previous highs by cutting prices and offering various promotions, Medisys reported this morning.
Margin improvements have been achieved faster than originally anticipated, it added. The company has benefited from cost saving measures implemented in the second half of the last financial year and cost reductions for its proprietary biosensor products.
Meanwhile, it has completed the development and manufacturing scale up of the first of the new systems it has designed for Menarini, the fifth largest worldwide branded marketer of blood glucose monitoring systems.
While the launch date is not yet clear, (Around March 1) Medisys predicted that sales of the products will be one of its key revenue growth drivers in the current financial year.


LATEST ON MDY V'S ROCHE COURT CASE
MDY V'S ROCHE COURT CASE Case IS Dismissed. http://www.moneyam.com/InvestorsRoom/posts.php?tid=8721#lastread
My apologies for any one that was on MDY it looks like we have been stitched up like a kipper the sale of Hypoguard blood glucose monitoring business at that price looks like an sp of 3p against the close of 6.4p what can I say no one could have seen this coming a total sell out and that is what I have done.

The sp is holding up well after the rise last week good support at 4p till we get the next bit of news.

next news....next rise...next week..

A recent article by proactive.

sounds like--stand on the edge and hold your nose!! this will probably send the sp up according to sod's law. still holding!

I have withdrawn the article from proactive, it had a lot of irregularities, and basically was a load of crap.

,

DRIVER I HAVE BEEN TOLD THESE ARE THE METERS THAT ARE BEING REPLACED BY
THE NEW GLUCOMEN VISIO YOU WILL FIND THEM IN THE MARCH - APRIL EDITON OF BALANCE THE MAG OF DIABETES UK
PAGE 3 IS A FULL PAGE ADD FOR MENARINI GLUCOMEN VISIO
PAGE 37 FULL PAGE ADD FOR GLUCOMEN VISIO

Mark
Cheers for that I think I will wait till the launch.

Interesting chart!

This is the new product that is going to be launched, nice AD

Menarini Diagnostics is a rapidly growing multi-national healthcare company with UK Headquarters in Wokingham, Berkshire. The company has been established in the UK for 18 years, and 2006 will see a major new product launch into the Diabetes self-testing market. The initial reaction to the product has been overwhelming and we are therefore looking to increase the size of our salesforce to meet customer demand. For this reason we are looking to recruit extra sales staff throughout the UK.

http://www.thegrocer.co.uk/GRJ_featured_employer.aspx?feid=1528

.

all good news for mdy.

Nice rise today, should see more upward moment on official launch of MDYS new product.

A very nice 1m buy and 1/2m just gone through this share is starting to pick up.

We have lift off 25% up.

Oh bugger.

KEAYDIAN
I take it your not in, there is still time buy on the drop MDY is a fast recovering stock back to 15p to 25p where it belongs IMO.

Watching in the background Driver but have limited access to a PC today.

Good pick, Driver (again). I have no spare at the moment, but I am jealous to death of your picking abilities.
Good luck all,
Alan